Escalon Medical Corp. (ESMC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 9 | 10 | 11 | 12 | 12 | 12 | 11 | - |
| Operating profit | $m | 0 | -1 | ||||||
| Net profit | $m | -1 | -0 | 0 | 0 | -0 | 0 | 2 | - |
| EPS reported | $ | 0.00 | 0.10 | ||||||
| Operating cashflow per share | $ | 0.05 | 37.84 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | 0.05 | 37.84 | ||||||
| Free cash flow | $m | 0 | 281 | ||||||
| Net debt | $m | -546 | -4,212 | ||||||
| Book value equity | $m | 2 | 4 | ||||||
| Book value per share | $ | 0.13 | 0.29 | ||||||
| Number of shares | m | 14.25 | 14.51 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 161.86 | 1.63 | ||||||
| P/B LTM | x | 1.25 | 0.58 | ||||||
| P/S LTM | x | 0.20 | 0.21 | ||||||
| P/FCF LTM | x | 6.31 | 0.01 | ||||||
| EV/EBITDA LTM | x | -3,269.84 | 603.43 | ||||||
| EV/Sales LTM | x | -45.07 | -291.83 | ||||||
| Earnings Yield LTM | % | +0.62% | +61.35% | ||||||
| FCF Yield | % | +15.86% | +11687.9% | ||||||
| Quality | |||||||||
| ROE | % | +5.51% | +77.88% | ||||||
| ROIC | % | +5.46% | -17.36% | ||||||
| Operating margin | % | +1.11% | -7.82% | ||||||
| Gross margin | % | +45.75% | +41.48% | ||||||
| FCF/Sales | % | +3.16% | +2451.4% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +0.54% | -4.47% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.73 | 277.63 | ||||||
| Net Debt/EBITDA | x | -3,284.30 | 3,714.03 | ||||||
| EBIT/Net interest | x | 0.01 | -55.03 | ||||||
| Net debt/market cap | % | +11.20% | +9.42% | ||||||
| Net debt/Equity | x | -284.88 | -1,015.91 | ||||||
| Gross debt/equity | x | 0.27 | 0.24 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free